Maryland Medicaid spent $68M in a year on obesity and diabetes drugs like Ozempic, Wegovy
Maryland’s Medicaid program now offers partial coverage of popular obesity drugs, with the state spending more than $68 ...
KSJB AM1 天
Which State Medicaid Programs Cover GLP-1s for Weight Loss & How Much Are They Spending?
The growing popularity of GLP-1 receptor agonists—including Ozempic and Wegovy from Novo Nordisk, and Mounjaro and Zepbound ...
People from some racial and ethnic groups may face barriers to obtaining obesity medications
Asians, non-Hispanic Blacks and Hispanics were significantly less likely than whites to use obesity-management medications to lower their weight compared with whites. The differences could not be ...